Survival among advanced non-small cell lung cancer patients with poor performance status after first-line chemotherapy

被引：0
|
作者：
Salloum, Ramzi George
Smith, Thomas J.
Jensen, Gail
Elston-Lafata, Jennifer
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
[3] Wayne State Univ, Detroit, MI USA
[4] Virginia Commonwealth Univ, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18144
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Drug development in patients with advanced non-small cell lung cancer and poor performance status
    Stinchcombe, TE
    Socinski, MA
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 21 - 26
  • [42] The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis
    Zhang, Yaxiong
    Fang, Wenfeng
    Yan, Yue
    Wang, Mengyao
    Kang, Shiyang
    Sheng, Jin
    Zhan, Jianhua
    Chen, Nan
    Hong, Shaodong
    Yang, Yunpeng
    Ma, Yuxiang
    He, Dacheng
    Qin, Tao
    Zhou, Ting
    Tang, Yanna
    He, Xiaobo
    Liang, Wenhua
    Zhang, Li
    [J]. MEDICAL ONCOLOGY, 2015, 32 (03)
  • [43] Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network
    Ritzwoller, Debra P.
    Carroll, Nikki M.
    Delate, Thomas
    Hornbrook, Mark C.
    Kushi, Lawrence
    Bowles, Erin J. Aiello
    Freml, Jared M.
    Huang, Karl
    Loggers, Elizabeth T.
    [J]. LUNG CANCER, 2012, 78 (03) : 245 - 252
  • [44] High glasgow prognostic score associates with a poor survival in Chinese advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy
    Su, Keju
    Wang, Xu
    Chi, Lumei
    Liu, Yang
    Jin, Lina
    Li, Wei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16353 - 16359
  • [45] Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer
    Cao, Wa
    Li, Ai-Wu
    Ren, Sheng-Xiang
    Chen, Xiao-Xia
    Li, Wei
    Gao, Guang-Hui
    He, Ya-Yi
    Zhou, Cai-Cun
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6799 - 6804
  • [46] A Phase Ⅱ Trial of Gefitinib as Maintenance Therapy after First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in China
    Lu Yang 1
    1Department of Thoracic Medical Oncology
    [J]. Chinese Journal of Cancer Research, 2010, 22 (01) : 1 - 9
  • [47] Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
    Crawford, Jeffrey
    Denduluri, Neelima
    Patt, Debra
    Jiao, Xiaolong
    Morrow, Phuong Khanh
    Garcia, Jacob
    Barron, Richard
    Lyman, Gary H.
    [J]. SUPPORTIVE CARE IN CANCER, 2020, 28 (02) : 925 - 932
  • [48] Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
    Jeffrey Crawford
    Neelima Denduluri
    Debra Patt
    Xiaolong Jiao
    Phuong Khanh Morrow
    Jacob Garcia
    Richard Barron
    Gary H. Lyman
    [J]. Supportive Care in Cancer, 2020, 28 : 925 - 932
  • [49] Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Kim, SW
    Suh, C
    Lee, SD
    Kim, WS
    Kim, DS
    Kim, WD
    Lee, JS
    [J]. LUNG CANCER, 2003, 41 (02) : 221 - 226
  • [50] Associations between biomarkers and outcomes of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC).
    Gronberg, B. H.
    Lund-Iversen, M.
    Strom, E. H.
    Brustugun, O. T.
    Scott, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345